In clinical trials, people who took semaglutide (Wegovy) lost an average of 15-20% of their body weight
By presenting a comprehensive, mechanistic, and clinically oriented overview, this article highlights the need for increased awareness among clinicians and underscores priorities for future research and preventive interventions in endocrine and reproductive health
Its designed to promote steady progress, improved digestion, and long-term balanceso your results last well beyond the treatment period
But theres a catch with that too (more on that later)
Many patients report feeling more satisfied with smaller portions, which contributes to an overall decrease in calorie intake
It adds that once patients stabilize at maintenance levels, headache incidence decreases significantly, making the symptom often transient rather than a permanent feature of treatment